Pursuant to section 23 of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply
or use in New Zealand of the new medicine set out in the Schedule hereto:
Schedule
Product: Synercid
Active Ingredients: Dalfopristin 350mg
Quinupristin 150mg
Dosage Form: Powder for infusion
New Zealand Sponsor: Aventis Pharma Limited
Manufacturer: DSM Pharmaceuticals Inc, Greenville, North Carolina, United States of America
Note: This consent is valid for two years from 20 June 2004.
Dated this 7th day of June 2004.
DON MATHESON, Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on 6 July 2001).